Thomas P. Monath
Corporate Officer/Principal at VAXXINITY, INC.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Mei Mei Hu | M | 41 | 10 years | |
Mason C. Kauffman | M | - |
US Biologic, Inc.
US Biologic, Inc. BiotechnologyHealth Technology US Biologic, Inc. develops and commercializes vaccines, anti-microbial and preventative therapeutics. Its solutions include tick-borne diseases, pet health, food-animal health, and predictive analytics. The company is headquartered in Memphis, TN. | - |
Chris Przybyszewski | M | - |
US Biologic, Inc.
US Biologic, Inc. BiotechnologyHealth Technology US Biologic, Inc. develops and commercializes vaccines, anti-microbial and preventative therapeutics. Its solutions include tick-borne diseases, pet health, food-animal health, and predictive analytics. The company is headquartered in Memphis, TN. | - |
Louis Reese | M | 42 | 10 years | |
Steve Zatechka | M | - |
US Biologic, Inc.
US Biologic, Inc. BiotechnologyHealth Technology US Biologic, Inc. develops and commercializes vaccines, anti-microbial and preventative therapeutics. Its solutions include tick-borne diseases, pet health, food-animal health, and predictive analytics. The company is headquartered in Memphis, TN. | - |
James Smith | M | 43 | 1 years | |
George Hornig | M | 69 | 2 years | |
Jason Pesile | M | 50 | 2 years | |
Peter Diamandis | M | 62 | 3 years | |
Barbara Harris | F | - |
Centers for Disease Control & Prevention
Centers for Disease Control & Prevention General GovernmentGovernment Centers for Disease Control and Prevention operates as a government health center. It helps to prevent and control infectious and chronic diseases, injuries, workplace hazards, disabilities and environmental health threats. It conducts research and investigations for its action oriented approach. The company was founded on July 1, 1946 and is located in Atlanta, GA. | 36 years |
Mark Joinnides | M | - | 4 years | |
Sumita Ray | F | 50 | 1 years | |
Gabrielle Toledano | F | 57 | 1 years | |
Landon Ogilvie | M | 46 | 1 years | |
Uwe Schlokat | M | - |
Sentinext Therapeutics Sdn. Bhd.
Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | - |
Jon Harrison | M | - | - | |
Zainul Fadziruddin Zainuddin | M | - |
Sentinext Therapeutics Sdn. Bhd.
Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | - |
Naser Jaafar | M | 60 |
Sentinext Therapeutics Sdn. Bhd.
Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | - |
Ganesh Kishore | M | 70 |
Sentinext Therapeutics Sdn. Bhd.
Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | 11 years |
Amy B. Fix | F | - | - | |
Brian Salmons | M | - |
Sentinext Therapeutics Sdn. Bhd.
Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | - |
Michael Shmerling | M | 68 |
US Biologic, Inc.
US Biologic, Inc. BiotechnologyHealth Technology US Biologic, Inc. develops and commercializes vaccines, anti-microbial and preventative therapeutics. Its solutions include tick-borne diseases, pet health, food-animal health, and predictive analytics. The company is headquartered in Memphis, TN. | - |
Amiruddin Azahar | M | - |
Sentinext Therapeutics Sdn. Bhd.
Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | - |
Lynn Austin | M | - |
Centers for Disease Control & Prevention
Centers for Disease Control & Prevention General GovernmentGovernment Centers for Disease Control and Prevention operates as a government health center. It helps to prevent and control infectious and chronic diseases, injuries, workplace hazards, disabilities and environmental health threats. It conducts research and investigations for its action oriented approach. The company was founded on July 1, 1946 and is located in Atlanta, GA. | 36 years |
David J. Williams | M | 74 |
US Biologic, Inc.
US Biologic, Inc. BiotechnologyHealth Technology US Biologic, Inc. develops and commercializes vaccines, anti-microbial and preventative therapeutics. Its solutions include tick-borne diseases, pet health, food-animal health, and predictive analytics. The company is headquartered in Memphis, TN. | - |
Christian Loucq | M | - |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | 22 years |
Elizabeth Brown | F | - |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | 28 years |
Tommy Thompson | M | 81 |
US Biologic, Inc.
US Biologic, Inc. BiotechnologyHealth Technology US Biologic, Inc. develops and commercializes vaccines, anti-microbial and preventative therapeutics. Its solutions include tick-borne diseases, pet health, food-animal health, and predictive analytics. The company is headquartered in Memphis, TN. | - |
Jon Yu | M | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Stanley Erck | M | 76 | 14 years | |
Fred Driscoll | M | 73 | 4 years | |
Jeffrey Church | M | 67 | 1 years | |
John A. Lambert | M | 71 |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | 5 years |
Jill Hoyt | F | - | 15 years | |
Evdoxia E. Kopsidas | F | 59 | 3 years | |
David Lawrence | M | 61 |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | 3 years |
Denis M. O'Donnell | M | 70 | 16 years | |
Bradley A. Perkins | M | 65 |
Centers for Disease Control & Prevention
Centers for Disease Control & Prevention General GovernmentGovernment Centers for Disease Control and Prevention operates as a government health center. It helps to prevent and control infectious and chronic diseases, injuries, workplace hazards, disabilities and environmental health threats. It conducts research and investigations for its action oriented approach. The company was founded on July 1, 1946 and is located in Atlanta, GA. | 32 years |
Manoj Ramjee | M | - |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | - |
Jayant Aphale | M | 63 |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | 2 years |
Stanley W. Merrill | M | - |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | 3 years |
Pincus Steven | M | - | - | |
William G. Turnell | M | - |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | 2 years |
De Xin Li | M | 71 |
U.S. Army Medical Research Institute for Infectious Diseases
| 4 years |
John Brown | M | 69 |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | 8 years |
Verla S. Neslund | F | - |
Centers for Disease Control & Prevention
Centers for Disease Control & Prevention General GovernmentGovernment Centers for Disease Control and Prevention operates as a government health center. It helps to prevent and control infectious and chronic diseases, injuries, workplace hazards, disabilities and environmental health threats. It conducts research and investigations for its action oriented approach. The company was founded on July 1, 1946 and is located in Atlanta, GA. | - |
Jim Robinson | M | - | 3 years | |
Martin Quibell | M | - |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | - |
Helene Gayle | M | 68 |
Centers for Disease Control & Prevention
Centers for Disease Control & Prevention General GovernmentGovernment Centers for Disease Control and Prevention operates as a government health center. It helps to prevent and control infectious and chronic diseases, injuries, workplace hazards, disabilities and environmental health threats. It conducts research and investigations for its action oriented approach. The company was founded on July 1, 1946 and is located in Atlanta, GA. | 17 years |
Len Stigliano | M | 76 | - | |
Rajiv Indravadan Modi | M | 64 | 13 years | |
Penny M. Heaton | M | 59 | - | |
Randal Chase | M | 74 |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | 6 years |
James M. Robinson | M | - | 3 years | |
William H. Gimson | M | - |
Centers for Disease Control & Prevention
Centers for Disease Control & Prevention General GovernmentGovernment Centers for Disease Control and Prevention operates as a government health center. It helps to prevent and control infectious and chronic diseases, injuries, workplace hazards, disabilities and environmental health threats. It conducts research and investigations for its action oriented approach. The company was founded on July 1, 1946 and is located in Atlanta, GA. | 28 years |
John Trizzino | M | 64 | 2 years | |
Joan Fusco | M | 68 |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | 4 years |
Peter John Fellner | M | 80 |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | 2 years |
Susan B. Bayh | F | 64 | - | |
Thomas Scoot Johnston | M | 53 | - | |
James Tananbaum | M | 60 | 3 years | |
Anthony Blandin | M | - | 7 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 44 | 70.97% |
United Kingdom | 13 | 20.97% |
Malaysia | 6 | 9.68% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Thomas P. Monath
- Personal Network